Bridging the future of cardiac stimulation: physiologic or leadless pacing?
cardiac stimulation
conduction system pacing
heart failure
leadless pacing
Journal
Reviews in cardiovascular medicine
ISSN: 1530-6550
Titre abrégé: Rev Cardiovasc Med
Pays: Singapore
ID NLM: 100960007
Informations de publication
Date de publication:
17 Mar 2022
17 Mar 2022
Historique:
received:
30
11
2021
revised:
11
01
2022
accepted:
26
01
2022
entrez:
29
3
2022
pubmed:
30
3
2022
medline:
19
4
2022
Statut:
ppublish
Résumé
Cardiac simulation has moved from early life-saving pacemakers meant only to prevent asystole to current devices capable of physiologic stimulation for the treatment of heart rhythm and heart failure, that are also intended for remote patient and disease-progression monitoring. The actual vision of contemporary pacing aims to correct the electrophysiologic roots of mechanical inefficiency regardless of underlying structural heart diseases. The awareness of the residual cardiac dyssynchrony related to customary cardiac pacing has changed the concept of what truly represents "physiologic pacing". On a different perspective, leadless stimulation to abolish CIED surgery and prevent lead-related complications is becoming a priority both for young device recipients and for frail, elderly patients. Careful clinical evaluation attempts to bridge decision-making to patient-tailored therapy.
Identifiants
pubmed: 35345274
pii: S1530-6550(22)00431-8
doi: 10.31083/j.rcm2303107
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
107Informations de copyright
© 2022 The Author(s). Published by IMR Press.
Déclaration de conflit d'intérêts
Mauro Biffi: educational activity and Speaker’s bureau for Biotronik, Boston Scientific, Medtronic, and Zoll. The other authors declare no conflicts of interest.